Bharat Biotech Seeks DCGI Nod for Covaxin Booster Trial Among Children Aged 2 to 18

Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in 2-18 age group

Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.

Bharat Biotech Seeks DCGI Nod for Covaxin Booster Trial Among Children Aged 2 to 18

The precaution dose of Covaxin and Covishield is being administered to all those above 18 years old and have completed nine months after the second dose

Bharat Biotech seeks DCGI nod for booster trial of Covaxin among kids aged 2-18 years

Bharat Biotech has sought DCGI’s approval to conduct phase 2/3 trial of its Covid-19 vaccine Covaxin as a booster shot among children aged 2-18 years old.

COVID-19 Vaccine Precaution Dose: Bharat Biotech Seeks DCGI's Permission to Conduct Covaxin Booster Trials in 2-18 Age Group

Bharat Biotech has also applied for the EUA for the 2-5 years old but Subject Expert Committee (SEC) has asked for more data. Bharat Biotech is the first company in India who had applied for permission from DCGI to conduct trials of a booster dose in the 2-18 age group. COVID-19 Vaccine Precaution Dose: Bharat Biotech Seeks DCGI's Permission to Conduct Covaxin Booster Trials in 2-18 Age Group.

Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

Presently, precaution dose of Covaxin and Covishield is administered to all those aged above 18 who have completed nine months after the second dose.

Bharat Biotech Seeks Nod For Covaxin Booster Trials For 2-18 Age Group

New Delhi:  Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population. According to a source, Bharat Biotech has sought approval from apex drug regulator Drug Controller General of India to conduct a Phase 2/3 study of Covaxin as a booster dose for […]The post Bharat Biotech Seeks Nod For Covaxin Booster Trials For 2-18 Age Group appeared first on…